05/08/2026
The conversation around autism, innovation, and family support should not be limited to one month.
We’re grateful to CNBC and Christopher Male of the Autism Impact Fund for helping bring attention to the need for continued progress in autism research and care.
At MARAbio, we are focused on helping families get answers earlier.
Our MAR-Autism™ Test is based on published, peer-reviewed research and identifies specific maternal autoantibody patterns associated with a subtype of autism. A positive result indicates over 97% risk of autism in future or current children, helping families and care teams have more informed conversations as early as possible.
Watch the CNBC segment here: https://youtu.be/bx6i9sVQPVc
Important to see continued focus on advancing autism research and innovation.As featured on CNBC, there is growing momentum around better understanding autis...